Financial News

CDC panel to review booster for children aged 5 to 11 as U.S. cases climb 57% from two weeks ago

A Centers for Disease Control and Prevention panel will meet to review a third dose of the vaccine developed by Pfizer and BioNTech for children aged 5 to 11.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback